Editorial Team
🌏 NMPANamed contributors covering Asia-Pacific Region pharmaceutical intelligence — 9 editors with published articles.
Quick answer
NovaPharmaNews Asia-Pacific Region edition lists 9 named editorial contributors with 404 published articles — NMPA drug approvals, clinical trials, manufacturing, and market intelligence attributed to accountable experts.
Contributors
- Dr. Yuki Tanaka MD, PhD APAC Regulatory Correspondent 208 articles Dr. Tanaka covers PMDA, NMPA, and TGA drug approval processes across the Asia-Pacific region.
- Dr. Priya Sharma MBBS, MSc Clinical Pharmacology Asia Clinical Research Editor 59 articles Dr. Sharma reports on clinical trials and drug development across India, China, and Southeast Asia.
- Dr. Grace Tan PharmD, RAC Senior Regulatory Intelligence Lead 24 articles Dr. Grace Tan provides senior analysis on regulatory convergence, inspection priorities, and quality compliance for APAC manufacturers. Her 19 years in regulatory operations make her a trusted voice on launch risk and remediation planning.
- Dr. Yuna Park MD, MPH Therapeutic Area Insights Editor 23 articles Dr. Yuna Park delivers APAC-focused therapeutic area intelligence spanning oncology, immunology, and cardiometabolic disease. With 11 years across clinical and editorial roles, she specializes in evidence synthesis for strategic planning.
- Dr. Mei Lin MD, MMed Medical Affairs and Evidence Writer 21 articles Dr. Mei Lin covers evidence generation, congress narratives, and medical communications strategy in APAC markets. Over 8 years, she has supported field medical teams in translating trial and real-world evidence into practical clinical positioning.
- Kenji Watanabe MBA, BSc Pharmacy APAC Pharma Strategy Editor 20 articles Kenji Watanabe leads APAC market coverage on portfolio strategy, launch prioritization, and cross-country commercialization. His 16 years in pharma strategy include advisory work for both multinational and regional specialty players.
- Arjun Menon BE, Biomedical Engineering Digital Health and AI Reporter 18 articles Arjun Menon tracks digital transformation in pharma, including AI-enabled R&D workflows and commercial analytics platforms. With 5 years in health-tech reporting, he focuses on practical adoption barriers and measurable business impact.
- Hiroshi Sato MEng, Bioprocessing Biologics Manufacturing Correspondent 16 articles Hiroshi Sato covers biologics process innovation, facility scale-up, and resilience planning across APAC supply chains. Over 12 years, he has reported on CDMO strategy and technical decisions that shape cost, quality, and speed.
- Isabella Cruz MSc, Public Health Regional Market Access Analyst 15 articles Isabella Cruz analyzes reimbursement policy, formulary pathways, and patient access trends across APAC health systems. In 9 years covering access strategy, she has focused on launch sequencing and evidence requirements by market.
Frequently asked questions
Who are the NovaPharmaNews editorial contributors?
This directory lists regional editors and analysts with published intelligence on NovaPharmaNews. Each profile shows credentials, coverage focus, and a full article archive for transparency and E-E-A-T.
How is regional coverage organised?
Authors are grouped by regional edition — Americas (FDA), Europe (EMA), or Asia-Pacific (PMDA/NMPA). Open a profile to see that contributor’s published news and analysis.
Where can I read the editorial standards?
See our Editorial Policy and Methodology pages for sourcing rules, correction process, and how human experts validate AI-assisted analysis.